Access to Research Data in the 21st Century: An Ongoing Dialogue Among Interested Parties: Report of a Workshop (2002)
Chapter: Appendix B: Agenda
Appendix B Agenda
Seeking Access to Research Data in the 21st Century: An Ongoing Dialogue Among Interested Parties Science, Technology, and Law Program The National Academies Washington, D.C.
March 12, 2001
Auditorium
|
7:30 |
Continental Breakfast – Great Hall |
|
8:00 |
Welcome Don Kennedy, President Emeritus, Stanford University, and Editor-in Chief, Science Cochair, Science, Technology, and Law Program |
|
8:20 |
Historical Perspective: Overview of Forsham v. Harris, the Shelby Amendment, Public Comment, OMB revisions to Circular A-110 OMB. Frederick R. Anderson, Jr., Partner, Cadwalader, Wickersham & Taft |
|
8:45 |
Question and Answer |
|
9:00 |
Panel 1: Understanding the scientific process: What is the universe of data, what is publication, how are scientific data validated? a. The scientific process from experimental design to data collection and analysis to publication/peer review. What is meta-analysis? What are its strengths and limitations? b. The Harvard Six Cities Study. What was the experimental design? What data were collected? What protections of confidentiality were promised to study participants? Moderator David Korn, Senior Vice President for Biomedical and Health Sciences Research, Association of American Medical Colleges Panelists: Steven Goodman, Associate Professor, Department of Biostatistics, Johns Hopkins University Douglas W. Dockery, Professor of Environmental Epidemiology and Professor of Medicine, Department of Environmental Health, Harvard Medical School |
|
10:10 |
Question and Answer |
|
10:30 |
Break – Great Hall |
|
10:45 |
Panel 2: Public accessibility to research data used in rule making. What is the problem? (Who should have access, and by what process, to data the agency relies on or proposes to rely on, and to data submitted by public and private entities seeking agency consideration? What are the countervailing concerns about permitting access to such data, and what protections must be in place to protect trade secrets, individual privacy, etc.?) Moderator Alan Morrison, Director, Public Citizen Litigation Group Panelists William L. Kovacs, Vice President, Environment, Technology, and Regulatory Affairs, U.S. Chamber of Commerce Bruce Alberts, President, National Academy of Sciences William H. Farland, Acting Deputy Assistant Administrator for Science, Office of Research and Development, U.S. Environmental Protection Agency |
|
|
Wendy Baldwin, Deputy Director for Extramural Research, National Institutes of Health David G. Hawkins, Director, Air and Energy Program, Natural Resources Defense Council Jim J. Tozzi, Member, Board of Advisors, Center for Regulatory Effectiveness |
|
12:30 |
Question and Answer |
|
1:00 |
Lunch – The Great Hall Protective Orders -The Impact of Secrecy on Public Health and Safety Decisions The Honorable Jack B. Weinstein, Senior Judge, United States District Court for the Eastern District of New York |
|
2:30 |
Panel 3: Alternative approaches to permitting public access to data used in regulatory/policy decisions Moderator Joel E. Cohen, Abby Rockefeller Mauze Professor and Head, Laboratory of Populations, The Rockefeller University and Professor of Populations, Columbia University Panelists Robert O’Keefe, Vice President, Health Effects Institute E. William Colglazier, Executive Officer, National Research Council Barry S. Kramer, Director, Office of Medical Applications of Research, National Institutes of Health Kenneth W. Harris, Acting Director, Research Data Center, National Center for Health Statistics |
|
3:40 |
Question and Answer |
|
4:00 |
Closing Richard A. Merrill, Daniel Caplin Professor of Law and Sullivan and Cromwell Research Professor of Law University of Virginia Law School Cochair, Science, Technology, and Law Program |
|
4:30 |
Reception – The Great Hall |
